Latest Articles
Endometrial Cancer Pipeline Outlook 2025 - Clinical Trials, - openPR.com
Endometrial Cancer Pipeline Outlook 2025 - Clinical Trials, openPR.com
Published: Aug. 20, 2025, 3:46 a.m.
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences - The Globe and Mail
Endometriosis Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Organon, Ironwood Pharma, Mitsubishi Tanabe Pharma Corp, AbbVie/Neurocrine Biosciences The Globe and Mail
Published: Aug. 6, 2025, 1:11 p.m.
Endometriosis market expected to reach $2.5bn across 7MM by 2034 - Clinical Trials Arena
Endometriosis market expected to reach $2.5bn across 7MM by 2034 Clinical Trials Arena
Published: July 1, 2025, 9:11 a.m.
Childhood traumatic events associated with endometriosis risk - Clinical Trials Arena
Childhood traumatic events associated with endometriosis risk Clinical Trials Arena
Published: June 17, 2025, 9:27 a.m.
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer - Clinical Trials Arena
Daiichi announces first subject dosing in Enhertu trial for endometrial cancer Clinical Trials Arena
Published: June 10, 2025, 9:06 a.m.
Endometriosis linked with increased risk of autoimmune disease - Clinical Trials Arena
Endometriosis linked with increased risk of autoimmune disease Clinical Trials Arena
Published: May 23, 2025, 3:24 p.m.
Endometrial Cancer Treatment Market 2034: Clinical Trials, - openPR.com
Endometrial Cancer Treatment Market 2034: Clinical Trials, openPR.com
Published: April 4, 2025, 4:30 a.m.
NHS approves long-term daily pill for endometriosis in England - Clinical Trials Arena
NHS approves long-term daily pill for endometriosis in England Clinical Trials Arena
Published: March 14, 2025, 2:22 p.m.
Ananda Pharma's MRX1 moves closer to clinical trials - ICYMI - Proactive Investors UK
Ananda Pharma's MRX1 moves closer to clinical trials - ICYMI Proactive Investors UK
Published: Feb. 22, 2025, 5:05 a.m.
Ananda Pharma's MRX1 moves closer to clinical trials after key milestone - Proactive Investors UK
Ananda Pharma's MRX1 moves closer to clinical trials after key milestone Proactive Investors UK
Published: Feb. 20, 2025, 3:20 p.m.
Link copied to clipboard!